Oregon one of six states to begin testing milk for H5N1 Avian Influenza
On Dec. 12, 2024, the Oregon Department of Agriculture (ODA), with significant input from Oregon’s dairy industry and…
-
-
Agriculture | Biotechnology | Diagnostics | Influenza | USDA | Vaccine
Arizona Department of Health Services reported first human H5N1 cases in Arizona
On Dec. 6, 2024, the Arizona Department of Health Services reported the first human H5N1 cases in Arizona….
-
Agriculture | Biotechnology | Influenza | USDA | Vaccine
USDA Announced New Federal Order, Begins National Milk Testing Strategy to Address H5N1 in Dairy Herds
On Dec. 6, 2024, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced…
-
CDC confirmed H5N1 Bird Flu Infection in a Child in California, first in U.S.
On Nov. 22, 2024, The Centers for Disease Control and Prevention (CDC) has confirmed a human infection with…
-
Oregon confirmed first human case of highly pathogenic avian influenza
On Nov. 15, 2024, the U.S. Centers for Disease Control and Prevention (CDC) confirmed a highly pathogenic avian…
-
Biotechnology | CDC | Diagnostics | Influenza | USDA | Vaccine
Avian Influenza Confirmed In Backyard Flock of Birds
On Nov. 15, 2024, The Hawai‘i Department of Agriculture (HDOA) received confirmation from the U.S. Department of Agriculture…
-
First case of H5 avian influenza reported in B.C.
On Nov. 9, 2024, the BC Centre for Disease Control’s Public-Health Laboratory reported that an an individual in…
-
Biotechnology | Diagnostics | Genomics | Influenza | Therapeutics | Vaccine
Scientists track emergence of novel H5N1 flu reassortant in Cambodia
On Nov. 6, 2024, researchers from the Pasteur Institute in Cambodia published a detailed genetic analysis of the…
-
Washington coast avian flu outbreak devastated Caspian terns, jumped to seals
Nov. 6, 2024, an epidemiological study found that 56% of a large breeding colony of Caspian terns died…
-
Agriculture | CDC | Influenza | Therapeutics | Vaccine
CDC Confirmed Human H5 Bird Flu Case in Missouri
On Sep. 6, 2024, the Centers for Disease Control and Prevention (CDC) confirmed a human case of avian…
-
New insights on how bird flu crosses the species barrier
On Aug. 19, 2024, scientists at the European Molecular Biology Laboratory (EMBL) published research that sheds light on…
-
Biotechnology | Influenza | Vaccine | WHO
New initiative launched to advance mRNA vaccine development against human avian influenza (H5N1)
On Jul. 29, 2024, a new project that aims to accelerate the development and accessibility of human avian…
-
Biotechnology | Influenza | Therapeutics | USDA | Vaccine | Veterinary
USDA Approved Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
On Jun. 25, 2024, Merck Animal Health announced U.S. Department of Agriculture (USDA) approval of NOBIVAC® NXT Canine…
-
Agriculture | Influenza | USDA | Veterinary
USDA confirmed detection of avian influenza in dairy cattle in Colorado
On Apr. 26, 2024, the Colorado Dept. of Agriculture reported that the U.S. Department of Agriculture’s (USDA) National…
-
Biotechnology | COVID-19 | FDA | Influenza | Vaccine
Pfizer and BioNTech received U.S. FDA Fast Track Designation for single-dose mRNA-based vaccine candidate against COVID-19 and influenza
On Dec. 9, 2022, Pfizer and BioNTech announced the companies had received Fast Track Designation from the U.S….
-
Newly licensed U.S. manufacturing facility increased availability of Fluzone high-dose quadrivalent (influenza vaccine)
On Jun. 17, 2021, the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research granted…
-
Biotechnology | COVID-19 | Influenza | NIH
Celdara Medical announced receipt of NIH funding for pandemic influenza antiviral development
On Aug. 12, 2020, Celdara Medical announced that the National Institute of Allergy and Infectious Diseases (NIAID) of…
-
USDA confirmed highly pathogenic H7N3 avian influenza in a commercial flock in Chesterfield County, South Carolina
On Apr. 9, 2020, the U.S. Department of Agriculture (USDA) confirmed the presence of highly pathogenic H7N3 avian…
-
BioAegis announced publication: ‘Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza’
On Dec. 12, 2019, BioAegis Therapeutics announced publication of new research findings with recombinant human plasma gelsolin in…
-
DARPA funded a $21.9 gene modulation research initiative at Georgia Tech, targeting influenza pandemics
In Jun. 2019, Defense Advanced Research Projects Agency (DARPA) announced it had funded a $21.9 gene modulation research…
-
FDA approved use of the 05 mL dose of Sanofi’s Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 months
On Jan. 23, 2019, U.S. Food and Drug Administration (FDA) announced it had approved approved the use of…
-
The American College of Obstetricians and Gynecologists released opinion on influenza vaccination in pregnancy
On Apr. 1, 2018, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices and the…
-
FDA approved expanded pediatric age indication for Fluarix Quadrivalent influenza vaccine
On Jan. 11, 2018, the U.S. Food and Drug Administration (FDA) approved an expanded indication for the four-strain…
-
Biotechnology | CDC | Influenza | Non-Profit Research | Radiology | Stem Cell | Vaccine
CDC published ACIP recommendations for prevention and control ofﾠ Haemophilus influenzaeﾠ type b (Hib) ﾠdisease
On Feb. 28, 2014, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
-
Biotechnology | FDA | Influenza | Vaccine
FDA approved quadrivalent formulation of Fluarix
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
-
A milestone in protection from influenza was reached with FDA approval for Novartis to manufacture seasonal influenza vaccine using cell-based technology in a US facility
On Nov. 20, 2012, the FDA approved a seasonal flu vaccine produced by Novartis using animal cell culture…
-
Biotechnology | FDA | Influenza | Vaccine
FDA approved first seasonal influenza vaccine manufactured using cell culture technology
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
-
ACIP recommended universal Influenza vaccination for those 6 months of age and older
On Feb. 24, 2010, the Immunization Practices Advisory Committee (ACIP) recommended universal Influenza vaccination for those 6 months…
-
FDA approved high-dose inactivated influenza vaccine for people ages 65 years and older
On Dec. 23, 2009, the FDA approved high-dose inactivated influenza vaccine (Fluzone High-Dose) for people ages 65 years…
-
swine flu outbreak declared a national emergency
On Oct. 24, 2009, President Barack Obama declared the swine flu (N1n1) outbreak a national emergency. The declaration…
